Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer

Author： Umemura Shigeki   Segawa Yoshihiko   Ueoka Hiroshi   Hotta Katsuyuki   Kiura Katsuyuki   Takigawa Nagio   Tabata Masahiro   Bessho Akihiro   Shinkai Tetsu   Tanimoto Mitsune  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.133, Iss.8, 2007-08, pp. : 519-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer

By Kim Young  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 342-350

Humana Press, Inc

Access to resources Recommend Favorite

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

By Han Ji-Youn   Lee Dae   Lee Sung   Park Chun   Kim Hae   Kim Eun-A   Yoon Sung   Lee Hong   Lee Jin  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 281-290

Humana Press, Inc

Access to resources Recommend Favorite

Modified one-day etoposide and cisplatin combination for previously untreated extensive-disease small-cell lung cancer: A retrospective evaluation of 36 cases

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 914-918

Science Publishers

Access to resources Recommend Favorite

Time Factor in Radiotherapy and Chemotherapy for Limited Disease Small-Cell Lung Cancer

By Nowara Elzbieta   Suwinski Rafal  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of chemotherapy in limited-disease small-cell lung cancer

By Kenmotsu Hirotsugu  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 483-492

Future Medicine

Access to resources Recommend Favorite